Potential therapeutic and pharmacological strategies for SARS-CoV2

BACKGROUND: At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Investig
Hlavní autoři: Ghareeb, Doaa A., Saleh, Samar R., Nofal, Mohammed S., Kaddah, Mohamed M. Y., Hassan, Salma. F., Seif, Inas K., El-Zahaby, Sally A., Khedr, Shaimaa M., Kenawy, Marwa Y., Masoud, Aliaa A., Soudi, Salma A., Sobhy, Ahmed A., Sery, Jaillan G., El-Wahab, Miral G. Abd, Elmoneam, Alshimaa A. Abd, Al-mahallawi, Abdulaziz Mohsen, El-Demellawy, Maha A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933375/
https://ncbi.nlm.nih.gov/pubmed/33688448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40005-021-00520-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky